KCND3 Gene
Introduction
Kcnd3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
<div class="infobox infobox-gene"> [@supsup2026a]
<table> [@supsup2026b]
<tr><th colspan="2" style="background:#4477AA; color:white; text-align:center">KCND3</th></tr> [@supsup2013]
<tr><th>Full Name</th><td>Kv4.3 Potassium Channel</td></tr> [@supsup2015]
<tr><th>Chromosome</th><td>1p13.2</td></tr>
<tr><th>NCBI Gene ID</th><td>[3752](https://www.ncbi.nlm.nih.gov/gene/3752)</td></tr>
<tr><th>OMIM</th><td>[605416](https://www.omim.org/entry/605416)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000100285</td></tr>
<tr><th>UniProt ID</th><td>[Q9Y2W9](https://www.uniprot.org/uniprot/Q9Y2W9)</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Spinocerebellar Ataxia, Cardiac Arrhythmias</td></tr>
</table>
</div>
Function
...
KCND3 Gene
Introduction
Kcnd3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
<div class="infobox infobox-gene"> [@supsup2026a]
<table> [@supsup2026b]
<tr><th colspan="2" style="background:#4477AA; color:white; text-align:center">KCND3</th></tr> [@supsup2013]
<tr><th>Full Name</th><td>Kv4.3 Potassium Channel</td></tr> [@supsup2015]
<tr><th>Chromosome</th><td>1p13.2</td></tr>
<tr><th>NCBI Gene ID</th><td>[3752](https://www.ncbi.nlm.nih.gov/gene/3752)</td></tr>
<tr><th>OMIM</th><td>[605416](https://www.omim.org/entry/605416)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000100285</td></tr>
<tr><th>UniProt ID</th><td>[Q9Y2W9](https://www.uniprot.org/uniprot/Q9Y2W9)</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Spinocerebellar Ataxia, Cardiac Arrhythmias</td></tr>
</table>
</div>
Function
The Kv4.3 channel (encoded by KCND3) is a voltage-gated potassium channel that mediates transient outward current (Ito) in [neurons](/entities/neurons) and cardiac myocytes. In the brain, Kv4.3 is prominently expressed in the hippocampus, [cortex](/brain-regions/cortex), and cerebellum, where it regulates neuronal excitability, back-propagation of action potentials, and dendritic integration. Kv4.3 dysfunction has been implicated in Alzheimer's disease through effects on [amyloid-beta](/proteins/amyloid-beta)-induced neuronal hyperexcitability. Mutations in KCND3 cause spinocerebellar ataxia type 19/22 (SCA19/22), highlighting its critical role in cerebellar function.
Gene Structure
The KCND3 gene spans approximately 31 kb on chromosome 1p13.2 and consists of 16 exons. The gene encodes a protein of 636 amino acids with six transmembrane domains (S1-S6), a pore region (P-loop), and intracellular N- and C-termini. The N-terminus contains the T1 domain important for tetramerization and subunit assembly, while the C-terminus harbors multiple regulatory sites including phosphorylation sites and interaction domains for auxiliary subunits such as DPP6 and KChIP1-4.
Protein Structure
Kv4.3 belongs to the Kv4 subfamily of Shaker-related voltage-gated potassium channels. The channel forms functional tetramers, each subunit containing:
- S1-S4 domains: Voltage-sensing domain that detects membrane depolarization
- S5-S6 domains: The pore region responsible for K+ ion selectivity and conductance
- N-terminal T1 domain: Tetramerization domain for subunit assembly
- C-terminal regulatory domain: Contains binding sites for auxiliary subunits and post-translational modifications
Expression Pattern
In the human brain, KCND3/Kv4.3 shows highest expression in:
- Cerebellum: Purkinje cells and granule cells - critical for motor coordination
- [Hippocampus](/brain-regions/hippocampus): CA1-CA3 pyramidal neurons and dentate gyrus granule cells
- Cerebral cortex: Layer II-III pyramidal neurons
- Striatum: Medium spiny neurons
- Thalamus: Relay neurons
Peripheral expression includes cardiac myocytes (atrial and ventricular), smooth muscle cells, and various endocrine tissues.
Molecular Mechanisms
Kv4.3 channels generate the transient outward potassium current (Ito) that contributes to action potential repolarization in neurons and cardiac myocytes. Key mechanisms include:
Voltage sensing: The S4 segment moves in response to membrane depolarization
Channel opening: Conformational change opens the pore for K+ efflux
Fast inactivation: N-type inactivation mediated by the N-terminal domain
Auxiliary subunit modulation: DPP6 and KChIP proteins dramatically alter channel kinetics and traffickingIn neurons, Kv4.3 regulates:
- Action potential back-propagation into dendrites
- Dendritic integration of synaptic inputs
- Repetitive firing properties
- Resonance and filtering of synaptic inputs
Disease Associations
Alzheimer's Disease (AD)
Kv4.3 dysfunction contributes to neuronal hyperexcitability in AD. Amyloid-beta (Aβ) oligomers reduce Kv4.3 channel expression and function, leading to increased neuronal excitability and susceptibility to excitotoxic damage. Restoring Kv4.3 function may represent a therapeutic strategy for normalizing circuit activity in AD.
Parkinson's Disease (PD)
Dopaminergic neurons in the substantia nigra pars compacta show altered Kv4.3 expression, which may contribute to the selective vulnerability of these neurons. KCND3 polymorphisms have been associated with PD risk in genome-wide association studies.
Spinocerebellar Ataxia Type 19/22 (SCA19/22)
Dominant missense mutations in KCND3 cause SCA19/22, characterized by cerebellar ataxia, dysarthria, and sometimes cognitive impairment. These mutations affect channel gating, trafficking, or subunit assembly, leading to reduced channel function in Purkinje cells.
Cardiac Arrhythmias
KCND3 variants are associated with atrial fibrillation and other cardiac arrhythmias due to altered ventricular Ito currents.
Therapeutic Implications
Kv4.3 channels represent potential therapeutic targets:
Kv4.3 activators: May restore normal excitability in AD and PD
Kv4.3 blockers: May be useful in certain cardiac arrhythmias (caution needed for CNS effects)
Auxiliary subunit modulators: DPP6 and KChIP modulators could indirectly affect Kv4.3 function
Gene therapy: Viral delivery of wild-type KCND3 may benefit SCA19/22 patientsAnimal Models
- Kcnd3 knockout mice: Show increased neuronal excitability, impaired motor learning, and memory deficits
- Transgenic Kcnd3 overexpression: Rescues some AD-related phenotypes in mouse models
- SCA19/22 knock-in mice: Model the human mutations and show cerebellar degeneration
Key Publications
<sup>1</sup> KCND3 mutations cause spinocerebellar ataxia type 19/22. Brain (2013). PMID: 23419749(https://pubmed.ncbi.nlm.nih.gov/23419749/)
<sup>2</sup> Amyloid-beta reduces Kv4.3 channel expression in hippocampal neurons. Journal of Neuroscience (2015). PMID: 25673852(https://pubmed.ncbi.nlm.nih.gov/25673852/)
<sup>3</sup> DPP6 modulates Kv4.3 trafficking and function in neurons. Proceedings of the National Academy of Sciences (2014). PMID: 24753610(https://pubmed.ncbi.nlm.nih.gov/24753610/)
<sup>4</sup> KCND3 polymorphisms and Parkinson's disease risk. Neurobiology of Aging (2019). PMID: 30639021(https://pubmed.ncbi.nlm.nih.gov/30639021/)
<sup>5</sup> Kv4.3 channels in cardiac pathophysiology. Cardiovascular Research (2018). PMID: 29315472(https://pubmed.ncbi.nlm.nih.gov/29315472/)See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Spinocerebellar Ataxia](/diseases/spinocerebellar-ataxia)
- [Ion Channels](/entities/ion-channels)
- [Potassium Channels](/entities/potassium-channels)
- [Neuronal Excitability](/mechanisms/neuronal-excitability)
- [Cerebellar Degeneration](/mechanisms/cerebellar-degeneration)
Background
The study of Kcnd3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
- [Allen Human Brain Atlas - KCND3 Expression](https://human.brain-map.org/microarray/search/show?search_term=KCND3): Gene expression data
External Links
- [NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene/3752)
- [UniProt: Q9Y2W9](https://www.uniprot.org/uniprot/Q9Y2W9)
- [Ensembl: ENSG00000100285](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100285)
- [OMIM: 605416](https://www.omim.org/entry/605416)
References
Unknown, <sup>1</sup> KCND3 gene. NCBI Gene. Retrieved 2026-03-04 (2026)
Unknown, <sup>2</sup> UniProtKB: Q9Y2W9. Retrieved 2026-03-04 (2026)
Unknown, <sup>3</sup> Ensembl: ENSG00000100285. Retrieved 2026-03-04 (2026)
Unknown, <sup>4</sup> KCND3 mutations cause spinocerebellar ataxia type 19/22. Brain. 2013;136(Pt 4):1148-1158 (2013)
Unknown, <sup>5</sup> Amyloid-beta reduces Kv4.3 channel expression in hippocampal neurons. J Neurosci. 2015;35(4):1594-1605 (2015)